Office of the Director; Notice of Meeting, 96021-96022 [2016-31611]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Notices
Dated: December 21, 2016.
Joanna Bare,
Executive Officer, Division of Management
Services, Center for Scientific Review, NIH.
[FR Doc. 2016–31543 Filed 12–28–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Vaccine
Advisory Committee
National Vaccine Program
Office, Office of the Assistant Secretary
for Health, Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that a meeting is scheduled to be held
for the National Vaccine Advisory
Committee (NVAC). The meeting will be
open to the public; public comment
sessions will be held during the
meeting.
SUMMARY:
The meeting will be held on
February 7 and 8, 2017. The meeting
times and agenda will be posted on the
NVAC Web site at https://www.hhs.gov/
nvpo/nvac/meetings/ as soon
as they become available.
ADDRESSES: Pre-registration is required
for members of the public who wish to
attend the meeting and who wish to
participate in the public comment
session. Individuals who wish to attend
the meeting and/or participate in the
public comment session should register
at https://www.hhs.gov/nvpo/nvac/
meetings/. Participants may
also register by emailing nvpo@hhs.gov
or by calling (202) 690–5566 and
providing their name, organization, and
email address.
U.S. Department of Health and Human
Services, Hubert H. Humphrey
Building, Great Hall, 200
Independence Avenue SW.,
Washington, DC 20201.
The meeting can also be accessed
through a live webcast on both days of
the meeting. For more information, visit
https://www.hhs.gov/nvpo/nvac/
meetings/.
FOR FURTHER INFORMATION CONTACT:
National Vaccine Program Office, U.S.
Department of Health and Human
Services, Room 715H, Hubert H.
Humphrey Building, 200 Independence
Avenue SW., Washington, DC 20201.
Phone: (202) 690–5566; email: nvpo@
hhs.gov.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
DATES:
VerDate Sep<11>2014
18:41 Dec 28, 2016
Jkt 241001
Pursuant
to Section 2101 of the Public Health
Service Act (42 U.S.C. 300aa–1), the
Secretary of Health and Human Services
was mandated to establish the National
Vaccine Program to achieve optimal
prevention of human infectious diseases
through immunization and to achieve
optimal prevention against adverse
reactions to vaccines. The NVAC was
established to provide advice and make
recommendations to the Director of the
National Vaccine Program on matters
related to the Program’s responsibilities.
The Assistant Secretary for Health
serves as Director of the National
Vaccine Program.
During the February 2017 NVAC
meeting, there will be a discussion of
the 21st Century Cures Act and
vaccines; an update on the recent
mumps outbreaks in the US;
presentations on Zika virus disease and
the status of Zika vaccine development;
presentations on vaccine adverse events
and insights from personalized
medicine; and the NVAC’s Mid-course
Review Working Group will present its
findings and draft recommendations for
deliberation and vote by the Committee.
Please note that agenda items are subject
to change as priorities dictate.
Information on the final meeting agenda
will be posted prior to the meeting on
the NVAC Web site: https://
www.hhs.gov/nvpo/nvac/.
Public attendance at the meeting is
limited to the available space.
Individuals who plan to attend in
person and need special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify the National Vaccine
Program Office at the address/phone
listed above at least one week prior to
the meeting. For those unable to attend
in person, a live webcast will be
available. More information on
registration and accessing the webcast
can be found at https://www.hhs.gov/
nvpo/nvac/meetings/.
Members of the public will have the
opportunity to provide comments at the
NVAC meeting during the public
comment periods designated on the
agenda. Public comments made during
the meeting will be limited to three
minutes per person to ensure time is
allotted for all those wishing to speak.
Individuals are also welcome to submit
their written comments. Written
comments should not exceed three
pages in length. Individuals submitting
written comments should email their
comments to the National Vaccine
Program Office (nvpo@hhs.gov) at least
five business days prior to the meeting.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
96021
Dated: December 21, 2016.
Bruce Gellin,
Designated Federal Officer, National Vaccine
Advisory Committee, Deputy Assistant
Secretary for Health.
[FR Doc. 2016–31530 Filed 12–28–16; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of a meeting of the NIH
Clinical Center Research Hospital
Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The portions of the meeting devoted
to the Anonymous Safety Hotline and
the laboratories or units and staff
involved in the individual reports to the
Hotline, staff, as well as discussions
regarding non-executive employees
holding specific positions in the
Clinical Center will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(9)(B) and 552b(c)(6), Title 5
U.S.C., as amended. Premature
disclosure of the laboratories or units
and staff involved in the individual
reports could significantly limit the
Hotline’s purpose by compromising
anonymity. Discussion of specific nonexecutive employees would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: NIH Clinical Center
Research Hospital Board.
Date: January 13, 2017.
Open: 8:30 a.m. to 12:30 p.m.
Agenda: Board Chair’s Overview, Remarks
from the NIH Director and the New CEO,
Clinical Center Focus Groups, Improving the
Clinical Center’s Census, Clinical Center
Patient and Worker Safety Metrics.
Open: 1:30 p.m. to 3:30 p.m.
Agenda: IT Infrastructure and Security,
Audits of Delayed Reporting—Self-Audit
Results and Formal Audit Planning, Facilities
Update.
Closed: 3:45 p.m. to Adjournment.
Agenda: Anonymous Safety Hotline,
Clinical Center Employees.
E:\FR\FM\29DEN1.SGM
29DEN1
96022
Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Notices
Place: Conference Room 6C6, Building 31,
National Institutes of Health, Bethesda, MD
20892.
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1 Room 126, Bethesda, MD 20892,
301–496–4272, woodgs@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Dated: December 23, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–31611 Filed 12–28–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group Microbiology and Infectious Diseases
Research Committee.
Date: January 26–27, 2017.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Frank S. De Silva, Ph.D.,
Scientific Review Officer, Scientific Review
VerDate Sep<11>2014
18:41 Dec 28, 2016
Jkt 241001
Program, Division of Extramural Activities,
Room #3E72A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9834,
Bethesda, MD 20892934, (240) 669–5023,
fdesilva@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 23, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–31568 Filed 12–28–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Initial Review Group; Neuroscience of
Aging Review Committee.
Date: February 2–3, 2017.
Time: 3:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Jeannette L. Johnson,
Ph.D., Deputy Review Branch Chief, National
Institutes of Health, National Institute on
Aging, Gateway Building, Bethesda, MD
20892, 301–402–7705, johnsonj9@
nia.nih.gov.
Name of Committee: National Institute on
Aging Initial Review Group; Behavior and
Social Science of Aging Review Committee.
Date: February 2–3, 2017.
Time: 3:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Kimberly Firth, Ph.D.,
National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Suite
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
2C212, Bethesda, MD 20892, 301–402–7702,
kimberly.firth@nih.gov.
Name of Committee: National Institute on
Aging Initial Review Group; Biological Aging
Review Committee.
Date: February 2–3, 2017.
Time: 4:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Bita Nakhai, Ph.D.,
Scientific Review Branch, National Institute
on Aging, Gateway Bldg., 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20814,
301–402–7701, nakhaib@nia.nih.gov.
Name of Committee: National Institute on
Aging Initial Review Group; Clinical Aging
Review Committee.
Date: February 2–3, 2017.
Time: 4:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Alicja L. Markowska,
Ph.D., D.Sc., National Institute on Aging,
National Institutes of Health, Gateway
Building 2C212, 7201 Wisconsin Avenue,
Bethesda, MD 20892, 301–496–9666,
markowsa@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 22, 2016.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–31433 Filed 12–28–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; P30 and P50
Revisions for AD Centers.
E:\FR\FM\29DEN1.SGM
29DEN1
]]>Agencies
[Federal Register Volume 81, Number 250 (Thursday, December 29, 2016)]
[Notices]
[Pages 96021-96022]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31611]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of a meeting of the NIH
Clinical Center Research Hospital Board.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The portions of the meeting devoted to the Anonymous Safety Hotline
and the laboratories or units and staff involved in the individual
reports to the Hotline, staff, as well as discussions regarding non-
executive employees holding specific positions in the Clinical Center
will be closed to the public in accordance with the provisions set
forth in section 552b(c)(9)(B) and 552b(c)(6), Title 5 U.S.C., as
amended. Premature disclosure of the laboratories or units and staff
involved in the individual reports could significantly limit the
Hotline's purpose by compromising anonymity. Discussion of specific
non-executive employees would constitute a clearly unwarranted invasion
of personal privacy.
Name of Committee: NIH Clinical Center Research Hospital Board.
Date: January 13, 2017.
Open: 8:30 a.m. to 12:30 p.m.
Agenda: Board Chair's Overview, Remarks from the NIH Director
and the New CEO, Clinical Center Focus Groups, Improving the
Clinical Center's Census, Clinical Center Patient and Worker Safety
Metrics.
Open: 1:30 p.m. to 3:30 p.m.
Agenda: IT Infrastructure and Security, Audits of Delayed
Reporting--Self-Audit Results and Formal Audit Planning, Facilities
Update.
Closed: 3:45 p.m. to Adjournment.
Agenda: Anonymous Safety Hotline, Clinical Center Employees.
[[Page 96022]]
Place: Conference Room 6C6, Building 31, National Institutes of
Health, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff Assistant, National
Institutes of Health, Office of the Director, One Center Drive,
Building 1 Room 126, Bethesda, MD 20892, 301-496-4272,
woodgs@od.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Dated: December 23, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-31611 Filed 12-28-16; 8:45 am]
BILLING CODE 4140-01-P
